Top Industry Stories – July 21, 2009 « Medical Dynamics

THE LATEST WORD

Top Industry Stories – July 21, 2009

Posted on July 21st, 2009 | by Rxmedyn | No Comments »

“Merck, Schering 2Q Profits Beat Views Despite Lower Sales” (Wall Street Journal)
“Stressed-out parents plus pollution boost asthma risk” (CNN)
“Drug industry, Pfizer lead in health lobbying” (The Associated Press)
“Incyte gets FDA nod on trial design, shares rise” (Reuters)
“Bayer says UK cost agency delays ruling on Nexavar” (Reuters)
“Elan Q2 revenues up 14 percent on Tysabri sales” (Reuters)
“Novartis says new version of Tekturna approved” (The Associated Press)
“WebMD Launches Free Mobile Application For Physicians” (Press release issued by WebMD Health Corp., PRNewswire)
“Elan gives J&J potential option to buy Biogen MS stake” (Reuters)
“Idenix shares fall following 2Q report, study data” (The Associated Press)
“Schering-Plough Reports Financial Results for 2009 Second Quarter” (Press release issued by Schering-Plough, PRNewswire)
“Merck Announces Second-Quarter 2009 Financial Results” (Press release issued by Merck and Co, Merck.com)
“Abbott’s new c4000 system delivers sophisticated science in a compact footprint” (Press release issued by Abbott Laboratories, PRNewswire)
“Landmark Five-Year African Study Indicates That HIV Therapy May Be Given Safely in Resource-Limited Settings Without Routine Laboratory Monitoring” (Press release issued by Gilead Sciences, Business Wire)
“FDA Approves Vaccine for 2009-2010 Seasonal Influenza” (Press release issued by FDA, FDA.gov)
“Spectrum gets fast-track status on bladder cancer drug” (Reuters)
“Industry Wary of Provisions in Healthcare Legislation” (FDA.gov)
“House Legislation Revamping Healthcare Passes Two Committees” (FDA.gov)
“96-Week MERIT ES Analysis Shows Efficacy Of Pfizer’s HIV/AIDS Treatment Celsentri/Selzentry (Maraviroc) In Treatment-Naïve HIV Patients; Results Consistent With 48-Week Analysis” (Press release issued by Pfizer, Business Wire)
“FDA Designates Fast Track Status for Apaziquone (EOquin(R)) for Bladder Cancer” (Press release issued by Allergan, Business Wire)
“Biotech leaps ahead in venture funding: report” (Reuters)
“Container AIDS labs could work across Africa: U.S. co” (Reuters)
“Teva Provides Update On Generic Ortho Tri-CyclenLo” (Press release issued by Teva Pharmaceuticals, Pharmaceutical Online)

Posted in Industry Stories

Leave a Reply

You must be logged in to post a comment.